Download PDF
Journal of Pediatric Epilepsy 2018; 07(02): 040-044
DOI: 10.1055/s-0038-1668588
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Antibody-Associated Autoimmune Encephalitis and Epilepsies in Children

Tuhina Govil
1   Carman and Ann Adams Departments of Pediatrics and Neurology, Children's Hospital of Michigan, Detroit Medical Center Wayne State University School of Medicine, Detroit, Michigan, United States
,
Mitchel T. Williams
1   Carman and Ann Adams Departments of Pediatrics and Neurology, Children's Hospital of Michigan, Detroit Medical Center Wayne State University School of Medicine, Detroit, Michigan, United States
› Author Affiliations
Further Information

Publication History

02 June 2018

20 June 2018

Publication Date:
03 September 2018 (online)

    Permissions and Reprints

Abstract

Autoimmune causes of epilepsy have become an increasingly recognized etiology, especially in treatment refractory cases. Over the past two decades, there has been an explosion of new biomarkers that have led to the identification of new syndromes. As the underlying pathophysiology is immune driven, their management and treatment are directed at the modulation of this abnormal immune response against self-antigens. These antibody-specific syndromes show variation between adult and pediatric populations. We focus this review article on those identified autoimmune encephalopathies and epilepsies and clinical differences between them as well as age-related variations that have been reported.

Keywords

autoimmune - epilepsy - encephalitis - pediatric
 

  • References

  • 1 Corsellis JA, Goldberg GJ, Norton AR. “Limbic encephalitis” and its association with carcinoma. Brain 1968; 91 (03) 481-496
    CrossrefPubMedGoogle Scholar
  • 2 Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000; 123 (Pt 7): 1481-1494
    CrossrefPubMedGoogle Scholar
  • 3 McKnight K, Jiang Y, Hart Y. , et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurology 2005; 65 (11) 1730-1736
    CrossrefPubMedGoogle Scholar
  • 4 Suleiman J, Wright S, Gill D. , et al. Autoantibodies to neuronal antigens in children with new-onset seizures classified according to the revised ILAE organization of seizures and epilepsies. Epilepsia 2013; 54 (12) 2091-2100
    CrossrefPubMedGoogle Scholar
  • 5 Granerod J, Ambrose HE, Davies NW. , et al; UK Health Protection Agency (HPA) Aetiology of Encephalitis Study Group. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010; 10 (12) 835-844
    CrossrefPubMedGoogle Scholar
  • 6 Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 2005; 58 (04) 594-604
    CrossrefPubMedGoogle Scholar
  • 7 Dalmau J, Tüzün E, Wu HY. , et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61 (01) 25-36
    CrossrefPubMedGoogle Scholar
  • 8 Florance NR, Davis RL, Lam C. , et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66 (01) 11-18
    CrossrefPubMedGoogle Scholar
  • 9 Sébire G, Devictor D, Huault G, Aicardi J, Landrieu P, Tardieu M. Coma associated with intense bursts of abnormal movements and long-lasting cognitive disturbances: an acute encephalopathy of obscure origin. J Pediatr 1992; 121 (06) 845-851
    CrossrefPubMedGoogle Scholar
  • 10 Zuliani L, Graus F, Giometto B, Bien C, Vincent A. Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psychiatry 2012; 83 (06) 638-645
    CrossrefPubMedGoogle Scholar
  • 11 Titulaer MJ, McCracken L, Gabilondo I. , et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12 (02) 157-165
    CrossrefPubMedGoogle Scholar
  • 12 Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10 (01) 63-74
    CrossrefPubMedGoogle Scholar
  • 13 Dalmau J, Gleichman AJ, Hughes EG. , et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7 (12) 1091-1098
    CrossrefPubMedGoogle Scholar
  • 14 Gresa-Arribas N, Titulaer MJ, Torrents A. , et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2014; 13 (02) 167-177
    CrossrefPubMedGoogle Scholar
  • 15 Byrne S, Walsh C, Hacohen Y. , et al. Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome. Neurol Neuroimmunol Neuroinflamm 2015; 2 (04) e130
    CrossrefPubMedGoogle Scholar
  • 16 Armangue T, Petit-Pedrol M, Dalmau J. Autoimmune encephalitis in children. J Child Neurol 2012; 27 (11) 1460-1469
    CrossrefPubMedGoogle Scholar
  • 17 Buckley C, Oger J, Clover L. , et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001; 50 (01) 73-78
    CrossrefPubMedGoogle Scholar
  • 18 Irani SR, Alexander S, Waters P. , et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010; 133 (09) 2734-2748
    CrossrefPubMedGoogle Scholar
  • 19 Lai M, Huijbers MG, Lancaster E. , et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010; 9 (08) 776-785
    CrossrefPubMedGoogle Scholar
  • 20 Lancaster E, Huijbers MG, Bar V. , et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 2011; 69 (02) 303-311
    CrossrefPubMedGoogle Scholar
  • 21 Hacohen Y, Singh R, Rossi M. , et al. Clinical relevance of voltage-gated potassium channel–complex antibodies in children. Neurology 2015; 85 (11) 967-975
    CrossrefPubMedGoogle Scholar
  • 22 Dhamija R, Renaud DL, Pittock SJ. , et al. Neuronal voltage-gated potassium channel complex autoimmunity in children. Pediatr Neurol 2011; 44 (04) 275-281
    CrossrefPubMedGoogle Scholar
  • 23 Malter MP, Frisch C, Schoene-Bake JC. , et al. Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity. J Neurol 2014; 261 (09) 1695-1705
    CrossrefPubMedGoogle Scholar
  • 24 Saiz A, Blanco Y, Sabater L. , et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008; 131 (Pt 10): 2553-2563
    CrossrefPubMedGoogle Scholar
  • 25 Petit-Pedrol M, Armangue T, Peng X. , et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 2014; 13 (03) 276-286
    CrossrefPubMedGoogle Scholar
  • 26 Daif A, Lukas RV, Issa NP. , et al. Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy. Epilepsy Behav 2018; 80: 331-336
    CrossrefPubMedGoogle Scholar
  • 27 Meinck HM, Faber L, Morgenthaler N. , et al. Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases. J Neurol Neurosurg Psychiatry 2001; 71 (01) 100-103
    CrossrefPubMedGoogle Scholar
  • 28 Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010; 67 (04) 470-478
    CrossrefPubMedGoogle Scholar
  • 29 Lin JJ, Lin KL, Hsia SH, Wang HS, Chou IJ, Lin YT. ; CHEESE Study Group. Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus. Pediatr Neurol 2012; 47 (04) 252-258
    CrossrefPubMedGoogle Scholar
  • 30 Mishra N, Rodan LH, Nita DA, Gresa-Arribas N, Kobayashi J, Benseler SM. Anti-glutamic Acid decarboxylase antibody associated limbic encephalitis in a child: expanding the spectrum of pediatric inflammatory brain diseases. J Child Neurol 2014; 29 (05) 677-683
    CrossrefPubMedGoogle Scholar
  • 31 Ben Achour N, Ben Younes T, Rebai I, Ben Ahmed M, Kraoua I, Ben Youssef-Turki I. Severe dysautonomia as a main feature of anti-GAD encephalitis: report of a paediatric case and literature review. Eur J Paediatr Neurol 2018; 22 (03) 548-551
    CrossrefPubMedGoogle Scholar
  • 32 Korff CM, Parvex P, Cimasoni L. , et al. Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition?. Arch Neurol 2011; 68 (08) 1065-1068
    CrossrefPubMedGoogle Scholar
  • 33 Lai M, Hughes EG, Peng X. , et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009; 65 (04) 424-434
    CrossrefPubMedGoogle Scholar
  • 34 Joubert B, Kerschen P, Zekeridou A. , et al. Clinical spectrum of encephalitis associated with antibodies against the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor: case series and review of the literature. JAMA Neurol 2015; 72 (10) 1163-1169
    CrossrefPubMedGoogle Scholar
  • 35 Nikolaus M, Knierim E, Meisel C. , et al. Severe GABAA receptor encephalitis without seizures: a paediatric case successfully treated with early immunomodulation. Eur J Paediatr Neurol 2018; 22 (03) 558-562
    CrossrefPubMedGoogle Scholar
  • 36 Spatola M, Petit-Pedrol M, Simabukuro MM. , et al. Investigations in GABAA receptor antibody-associated encephalitis. Neurology 2017; 88 (11) 1012-1020
    CrossrefPubMedGoogle Scholar
  • 37 Lancaster E, Lai M, Peng X. , et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2010; 9 (01) 67-76
    CrossrefPubMedGoogle Scholar
  • 38 Höftberger R, Titulaer MJ, Sabater L. , et al. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 2013; 81 (17) 1500-1506
    CrossrefPubMedGoogle Scholar
  • 39 Caputo D, Iorio R, Vigevano F, Fusco L. Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABAAR antibodies. Eur J Paediatr Neurol 2018; 22 (01) 182-185
    CrossrefPubMedGoogle Scholar
  • 40 van Baalen A, Häusler M, Boor R. , et al. Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia 2010; 51 (07) 1323-1328
    CrossrefPubMedGoogle Scholar
  • 41 Lee J, Yu HJ, Lee J. Hashimoto encephalopathy in pediatric patients: homogeneity in clinical presentation and heterogeneity in antibody titers. Brain Dev 2018; 40 (01) 42-48
    CrossrefPubMedGoogle Scholar
  • 42 Henchey R, Cibula J, Helveston W, Malone J, Gilmore RL. Electroencephalographic findings in Hashimoto's encephalopathy. Neurology 1995; 45 (05) 977-981
    CrossrefPubMedGoogle Scholar
  • 43 Berger I, Castiel Y, Dor T. Paediatric Hashimoto encephalopathy, refractory epilepsy and immunoglobulin treatment - unusual case report and review of the literature. Acta Paediatr 2010; 99 (12) 1903-1905
    CrossrefPubMedGoogle Scholar
  • 44 Maas A, Braun KP, Geleijns K, Jansen FE, van Royen-Kerkhof A. Risks and benefits of rituximab in the treatment of Hashimoto encephalopathy in children: two case reports and a mini review. Pediatr Neurol 2017; 66: 28-31
    CrossrefPubMedGoogle Scholar
  • 45 Graus F, Titulaer MJ, Balu R. , et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016; 15 (04) 391-404
    CrossrefPubMedGoogle Scholar